Cathepsin L Inhibitor I features a peptide-based inhibitory motif designed to probe cysteine protease recognition. Functional groups establish key interactions in the active site and support mechanistic evaluation. Researchers assess its binding constants and conformational preferences. Applications include enzyme inhibition research, structural mapping, and selectivity analysis.
CAT No: R2713
CAS No:108005-94-3
Synonyms/Alias:Cathepsin L Inhibitor I;108005-94-3;Z-Phe-Phe-FMK;Z-Phe-Phe-Fluoromethylketone;Cathepsin L-IN-2;benzyl N-[1-[(4-fluoro-3-oxo-1-phenylbutan-2-yl)amino]-1-oxo-3-phenylpropan-2-yl]carbamate;Z-FF-FMK?;SCHEMBL9195401;BDBM110185;EX-A4898;AKOS040756455;DA-68878;HY-115733;CS-0255057;
Cathepsin L Inhibitor I is a specialized small-molecule compound designed to selectively inhibit the activity of cathepsin L, a lysosomal cysteine protease involved in a wide range of cellular processes. This inhibitor is valued in biochemical research for its high specificity and ability to modulate proteolytic pathways, making it a powerful tool for dissecting the roles of cathepsin L in cellular and molecular biology. Its application extends across multiple research domains where precise control of protease activity is essential for unraveling complex biological mechanisms. Cathepsin L Inhibitor I is often utilized in in vitro studies, cell-based assays, and molecular investigations that require targeted interruption of cathepsin L-mediated cleavage events. The compound is supplied as a convenient reagent, compatible with diverse experimental systems, and is frequently used by researchers aiming to elucidate the function of cathepsin L in health and disease models.
Protease Activity Studies: Cathepsin L Inhibitor I is widely employed in protease activity assays, enabling researchers to selectively block cathepsin L and thereby analyze its contribution to proteolytic cascades within cells or tissue extracts. By incorporating this inhibitor into enzymatic assays, scientists can differentiate between cathepsin L-dependent and independent pathways, facilitating the identification of substrates and the mapping of protease networks. Such studies are crucial for understanding the regulation of protein turnover and the maintenance of cellular homeostasis.
Protein Degradation Pathways: In the context of protein degradation research, Cathepsin L Inhibitor I serves as a key reagent for dissecting the role of lysosomal proteases in autophagy and endolysosomal processing. By inhibiting cathepsin L, investigators can assess its involvement in the breakdown of long-lived proteins and organelles, as well as its interplay with other cathepsins and proteolytic systems. This approach aids in clarifying how cells respond to stress, manage misfolded proteins, and maintain proteostasis under various physiological and experimental conditions.
Cell Signaling Investigations: Cathepsin L Inhibitor I is instrumental in studies exploring the impact of protease activity on cell signaling pathways. Cathepsin L is known to process a variety of signaling precursors and membrane proteins, influencing pathways related to cell growth, differentiation, and immune responses. By using this inhibitor, researchers can monitor changes in signaling cascades and downstream gene expression, providing insights into the regulatory roles of cathepsin L and the consequences of its dysregulation.
Extracellular Matrix Remodeling: The inhibitor is also applied in research focused on extracellular matrix (ECM) remodeling, where cathepsin L participates in the degradation of structural proteins such as collagen and elastin. Blocking its activity with Cathepsin L Inhibitor I allows for the investigation of matrix turnover, tissue remodeling, and the molecular mechanisms underlying cell migration and invasion. These studies are particularly relevant in developmental biology, tissue engineering, and models of pathological tissue remodeling.
Viral Entry and Host-Pathogen Interactions: Cathepsin L Inhibitor I has been leveraged in virology research to probe the involvement of host proteases in viral entry processes. Certain viruses exploit cathepsin L to activate their fusion proteins and facilitate entry into host cells. By inhibiting this protease, scientists can dissect the molecular events governing viral infection and host-pathogen interactions, paving the way for a deeper understanding of viral life cycles and potential intervention strategies.
Collectively, Cathepsin L Inhibitor I is a versatile and indispensable tool for researchers investigating protease function, protein degradation, cellular signaling, extracellular matrix dynamics, and host-pathogen relationships. Its targeted mechanism of action supports a range of experimental approaches, from basic biochemical assays to complex cell-based models, advancing knowledge in cell biology, molecular pathology, and infectious disease research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.